0001654954-19-009162.txt : 20190809
0001654954-19-009162.hdr.sgml : 20190809
20190809154120
ACCESSION NUMBER: 0001654954-19-009162
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190807
FILED AS OF DATE: 20190809
DATE AS OF CHANGE: 20190809
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Camber Capital Management LP
CENTRAL INDEX KEY: 0001444043
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10865
FILM NUMBER: 191012831
BUSINESS ADDRESS:
STREET 1: 101 HUNTINGTON AVENUE
STREET 2: SUITE 2101
CITY: BOSTON
STATE: MA
ZIP: 02199
BUSINESS PHONE: 617-717-6600
MAIL ADDRESS:
STREET 1: 101 HUNTINGTON AVENUE
STREET 2: SUITE 2101
CITY: BOSTON
STATE: MA
ZIP: 02199
FORMER NAME:
FORMER CONFORMED NAME: Camber Capital Management LLC
DATE OF NAME CHANGE: 20080827
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000792977
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 042742593
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1100 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 6174983300
MAIL ADDRESS:
STREET 1: 1100 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: AMAG PHARMACEUTICALS INC.
DATE OF NAME CHANGE: 20070724
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MAGNETICS INC
DATE OF NAME CHANGE: 19920703
4
1
section16.xml
FORM 4
X0306
4
2019-08-07
0000792977
AMAG PHARMACEUTICALS, INC.
AMAG
0001444043
Camber Capital Management LP
101 HUNTINGTON AVENUE
SUITE 2101
BOSTON
MA
02199
true
Common Stock
2019-08-07
2019-08-07
4
P
false
301000
7.7857
A
4306000
I
See Footnotes
Common Stock
2019-08-07
2019-08-07
4
P
false
50000
7.74
A
4356000
I
See Footnotes
Common Stock
2019-08-07
2019-08-07
4
P
false
4000
7.575
A
4360000
I
See Footnotes
Common Stock
2019-08-09
2019-08-09
4
P
false
26600
8.9395
A
4386600
I
See Footnotes
Common Stock
2019-08-09
2019-08-09
4
P
false
3400
9.1781
A
4390000
I
See Footnotes
Securities reported herein for Camber Capital Management LP (the "LP" ) represent Common Stock beneficially owned and held of record by Camber Capital Master Fund, L.P. (the "Master Fund") and another private investment fund (the "Fund") for which the LP serves as the investment manager. Stephen DuBois is the managing member of the LP and managing member of the general partner for the Fund and the Master Fund. The LP, the Master Fund, the Fund, the general partner and Mr. DuBois (the "Reporting Persons") are each beneficial owners and have an address of 101 Huntington Avenue, Floor 21, Boston, MA 02199. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares in which the Reporting Persons have no actual pecuniary interest therein.
Of the securities reported for this transaction, 299,074 shares of Common Stock were purchased for the account of the Master Fund and 1,926 shares of Common Stock were purchased for the account of the Fund
Of the securities reported for this transaction, 49,680 shares of Common Stock were purchased for the account of the Master Fund and 320 shares of Common Stock were purchased for the account of the Fund
Of the securities reported for this transaction, 3,974 shares of Common Stock were purchased for the account of the Master Fund and 26 shares of Common Stock were purchased for the account of the Fund
Of the securities reported for this transaction, 26,430 shares of Common Stock were purchased for the account of the Master Fund and 170 shares of Common Stock were purchased for the account of the Fund
Of the securities reported for this transaction, 3,378 shares of Common Stock were purchased for the account of the Master Fund and 22 shares of Common Stock were purchased for the account of the Fund
As of the closing of trading on August 09, 2019, 4,361,316 shares of Common Stock were held for the account of the Master Fund and 28,684 shares of Common Stock were held for the account of the Fund.
/s/ Stephen DuBois
2019-08-09